Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1149192C details a scalable Raney Nickel route for quinolone intermediates, eliminating hazardous reagents and improving purity for reliable API supplier partnerships.
Novel patent CN106966912B enables efficient Dolutegravir intermediate production with high optical purity and scalable manufacturing processes for global supply chains.
Patent CN106188049A reveals a novel route for antitumor intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity pharmaceutical ingredients.
Novel Pd-catalyzed route for silicon heterocycles. Mild conditions, high purity. Ideal for pharma intermediates supply chain optimization and cost reduction.
Discover a transition metal-free synthesis for aza aromatic amines. This patent offers significant cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN114181169A details a green, metal-free route to N-substituted benzothiazin-4-ones, offering cost reduction in fine chemical manufacturing and high purity.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104876997A reveals optimized glycyrrhetinic acid modification. Achieve high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Patent CN116730993A reveals a novel Ir-catalyzed route for Teranavir. Achieve high-purity HIV protease inhibitors with reduced steps and cost reduction in API manufacturing.
Discover the novel AgOTf-catalyzed synthesis of allyl thiomethyl ethers from olefins and DMSO. A cost-effective, high-yield route for pharmaceutical intermediates.
Patent CN102381947B details a green 3-step synthesis for high-purity chiral 2,2'-dialkoxy-1,1'-binaphthyl, offering significant cost reduction and supply chain reliability.
Patent CN111620860B reveals a streamlined synthesis for Afuresertib, eliminating complex protection steps for significant cost reduction and supply chain reliability in AKT inhibitor manufacturing.
Patent CN109134173B reveals a green DMSO-mediated oxidation method for heterocyclic ketones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110372544A reveals low-cost iron-titanium catalysis for biaryl synthesis. Achieve significant cost reduction and supply chain reliability in pharmaceutical intermediate manufacturing.
Patent CN108997332B reveals a safe, high-yield catalytic transfer hydrogenation route for dihydroberberine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel enzymatic process enhances yield and purity while reducing equipment corrosion for reliable supply chains and cost effective manufacturing solutions in global markets.
Environment-friendly synthesis of 1,4-Cyclohexanedione from hydroquinone. High yield, scalable process for pharmaceutical intermediates manufacturing.
Patent CN101875666B details a novel asymmetric synthesis for high-purity 1,3-alkamine compounds, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel base-catalyzed method for phosphinate derivatives ensures high yield and safety. Ideal for reliable supply chain and cost reduction in fine chemical manufacturing.
Novel Pd-catalyzed method for Z-allyl amino acids via azlactones. High stereoselectivity, mild conditions. Ideal for reliable pharmaceutical intermediate supplier needs.